A randomised, multicentre study of ceftriaxone versus standard therapy in the treatment of lower respiratory tract infections.

G. J. D. Klerk,J.H.M. van Steijn,S. Lobatto,C.A.J.J. Jaspers,Wim C. J. Veldhuizen,C.A.J. Hensing,M.C.M. Bunnik,W. Geraedts,A.S.M. Dofferhof,J. V. D. Berg,J.H.J.M. Melis,A.I.M. Hoepelman
DOI: https://doi.org/10.1016/S0924-8579(99)00037-0
IF: 15.441
1999-07-01
International Journal of Antimicrobial Agents
Abstract:
What problem does this paper attempt to address?